This document discusses anti-leprosy drugs used to treat leprosy caused by Mycobacterium leprae. It classifies these drugs into sulfones like dapsone, antitubercular drugs like rifampicin, phenazine derivatives like clofazimine, and antibiotics like ofloxacin. It outlines the mechanisms and dosages of major drugs. The WHO recommended multidrug therapy regimen combines dapsone, clofazimine and rifampicin given daily or monthly depending on type of leprosy. It also discusses drugs used to treat type II leprosy reactions like corticosteroids. Nursing responsibilities involve assessing patients for side effects and providing education on long term adherence